anmeldenSLI
2.288,17
PKT
-5,12
PKT
-0,22
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.06.16 | UBS Underperform | BNP PARIBAS | |
| 10.06.16 | Richemont buy | HSBC | |
| 09.06.16 | UBS Halten | Independent Research GmbH | |
| 09.06.16 | UBS Equal-Weight | Morgan Stanley | |
| 09.06.16 | UBS overweight | Barclays Capital | |
| 09.06.16 | UBS Equal weight | Barclays Capital | |
| 08.06.16 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 07.06.16 | Roche overweight | JP Morgan Chase & Co. | |
| 07.06.16 | UBS buy | UBS AG | |
| 06.06.16 | Nestlé overweight | Morgan Stanley | |
| 06.06.16 | UBS Hold | Deutsche Bank AG | |
| 06.06.16 | Roche Hold | HSBC | |
| 06.06.16 | UBS buy | Goldman Sachs Group Inc. | |
| 01.06.16 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 01.06.16 | UBS Neutral | Goldman Sachs Group Inc. | |
| 01.06.16 | UBS buy | Goldman Sachs Group Inc. | |
| 01.06.16 | Richemont Outperform | BNP PARIBAS | |
| 01.06.16 | Nestlé Neutral | UBS AG | |
| 31.05.16 | Roche overweight | Morgan Stanley | |
| 31.05.16 | Novartis Underweight | Morgan Stanley | |
| 31.05.16 | Roche overweight | JP Morgan Chase & Co. | |
| 31.05.16 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 27.05.16 | UBS Neutral | JP Morgan Chase & Co. | |
| 27.05.16 | Nestlé overweight | JP Morgan Chase & Co. | |
| 27.05.16 | Givaudan Underweight | Barclays Capital | |
| 27.05.16 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 26.05.16 | Nestlé overweight | JP Morgan Chase & Co. | |
| 26.05.16 | Novartis overweight | JP Morgan Chase & Co. | |
| 26.05.16 | UBS Hold | Deutsche Bank AG | |
| 26.05.16 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 25.05.16 | Holcim Neutral | JP Morgan Chase & Co. | |
| 25.05.16 | Nestlé Sell | Goldman Sachs Group Inc. | |
| 25.05.16 | Richemont buy | Goldman Sachs Group Inc. | |
| 24.05.16 | Richemont Outperform | Robert W. Baird & Co. Incorporated | |
| 24.05.16 | Richemont Neutral | Credit Suisse Group | |
| 24.05.16 | Richemont Underperform | Macquarie Research | |
| 24.05.16 | Richemont market-perform | Bernstein Research | |
| 24.05.16 | Swiss Re Neutral | UBS AG | |
| 23.05.16 | Richemont buy | Kepler Cheuvreux | |
| 23.05.16 | Richemont Hold | Société Générale Group S.A. (SG) |
